Transient Ischemic Attack (TIA) Clinical Trials

7 recruitingLast updated: June 18, 2026

There are 7 actively recruiting transient ischemic attack (tia) clinical trials across 5 countries. Studies span Not Applicable. Top locations include Beijing, China, Birmingham, Alabama, United States, Bologna, Italy. Updated daily from ClinicalTrials.gov.


Transient Ischemic Attack (TIA) Trials at a Glance

7 actively recruiting trials for transient ischemic attack (tia) are listed on ClinicalTrialsFinder across 6 cities in 5 countries. The largest study group is Not Applicable with 4 trials, with the heaviest enrollment activity in Beijing, Birmingham, and Bologna. Lead sponsors running transient ischemic attack (tia) studies include Beijing Tiantan Hospital, IRCCS Azienda Ospedaliero-Universitaria di Bologna, and Tang-Du Hospital.

Browse transient ischemic attack (tia) trials by phase

About Transient Ischemic Attack (TIA) Clinical Trials

Looking for clinical trials for Transient Ischemic Attack (TIA)? There are currently 7 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Transient Ischemic Attack (TIA) trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Transient Ischemic Attack (TIA) clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 17 of 7 trials

Recruiting
Not Applicable

Pharmacogenomics in Stroke: Feasibility of CYP2C19 Testing

StrokeTransient Ischemic Attack (TIA)
University of Alabama at Birmingham200 enrolled1 locationNCT06943586
Recruiting
Not Applicable

Ambulatory Stroke Unit Treatment for Elderly Patients

Retinal ischemiaIschemic StrokeTransient Ischemic Attack (TIA)
University Hospital Heidelberg400 enrolled1 locationNCT07420374
Recruiting
Not Applicable

Secondary Prevention of Ischemic Stroke and Transient Ischemic Attack With an Intelligent Management System

Ischemic StrokeTransient Ischemic Attack (TIA)
Beijing Tiantan Hospital4,490 enrolled3 locationsNCT06783049
Recruiting
Not Applicable

Effect of the Intelligent Lipid Management Decision-support System on 1-year LDL-C Target Achievement in Ischemic Stroke or TIA Patients Under Evolocumab Treatment in China

Ischemic StrokeTransient Ischemic Attack (TIA)
Beijing Tiantan Hospital4,000 enrolled1 locationNCT07143149
Recruiting

Types of Intracellular Bacteria in Atherosclerotic Plaques and Analysis of Risk Factors

DiabetesCarotid Artery StenosisHyperlipidemia+6 more
Tang-Du Hospital200 enrolled1 locationNCT06935279
Recruiting

Canadian TIA Score Versus ABCD2 Score in Risk Stratification of Transient Ischemic Attack (TIA)

Transient Ischemic Attack (TIA)
IRCCS Azienda Ospedaliero-Universitaria di Bologna800 enrolled1 locationNCT06718075
Recruiting

Population-based Brest Stroke Registry

StrokeCerebrovascular DisordersIschemic Stroke+6 more
University Hospital, Brest15,000 enrolled1 locationNCT02900521